跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,065 条关于
“Neuroblastoma Australia”
全部
3,065
临床试验
895
药物
47
机构
496
资讯
1,627
去年
Australia Approves IFINWIL (Eflornithine) for High-Risk Neuroblastoma Treatment
9个月前
Australian Researchers Identify Romidepsin as Breakthrough Treatment for Relapsed Neuroblastoma
去年
Cuprior Shows Promise in Treating High-Risk Neuroblastoma in Children
去年
Norgine Seeks EMA Approval for Eflornithine in High-Risk Neuroblastoma
3个月前
RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma
2个月前
Family Raises £100,000 for DFMO Access to Prevent Neuroblastoma Relapse in Two-Year-Old UK Girl
去年
CHOP Researchers Propose ALK Inhibitors as New Standard for Hereditary Neuroblastoma
上个月
Risk-Adapted Frameworks Reshape Pediatric Neuroblastoma Care, New Review Shows
2年前
Eflornithine (DFMO) Shows Promise in Neuroblastoma Treatment, Receives FDA Approval
5个月前
FDA Grants Fast Track Designation to Daretabart for High-Risk Neuroblastoma Treatment
第 1 页,共 163 页
上一页
下一页